scholarly journals Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus

2014 ◽  
Vol 171 (24) ◽  
pp. 5636-5649 ◽  
Author(s):  
Danit Mechlovich ◽  
Tamar Amit ◽  
Orit Bar-Am ◽  
Orly Weinreb ◽  
Moussa B H Youdim
2019 ◽  
Vol 10 ◽  
Author(s):  
Liqing Zang ◽  
Yasuhito Shimada ◽  
Hiroko Nakayama ◽  
Wenbiao Chen ◽  
Ayaka Okamoto ◽  
...  

Author(s):  
Angela W.S. Lee ◽  
Roger D. Cox

The use of mouse models in medical research has greatly contributed to our understanding of the development of type 2 diabetes mellitus and the mechanisms of disease progression in the context of insulin resistance and β-cell dysfunction. Maintenance of glucose homeostasis involves a complex interplay of many genes and their actions in response to exogenous stimuli. In recent years, the availability of large population-based cohorts and the capacity to genotype enormous numbers of common genetic variants have driven various large-scale genome-wide association studies, which has greatly accelerated the identification of novel genes likely to be involved in the development of type 2 diabetes. The increasing demand for verifying novel genes is met by the timely development of new mouse resources established as various collaborative projects involving major transgenic and phenotyping centres and laboratories worldwide. The surge of new data will ultimately enable translational research into potential improvement and refinement of current type 2 diabetes therapy options, and hopefully restore quality of life for patients.


2017 ◽  
Vol 178 ◽  
pp. 166-171 ◽  
Author(s):  
Rebecca L. Erickson ◽  
Caroline A. Browne ◽  
Irwin Lucki

Sign in / Sign up

Export Citation Format

Share Document